EV

Eline Van Beest

Venture Partner at Thuja Capital

The Hague, South Holland

Overview 

Eline van Beest is a Medtech & Biotech Entrepreneur, Investor, and Boardmember based in The Hague, South Holland. She currently serves as the Chief Executive Officer of Hybridize Therapeutics and has held leadership roles at Thuja Capital, NightBalance, and LivAssured BV. Eline's career highlights include founding NightBalance and co-founding Blue Sparrows MedTech Fund, showcasing her expertise in entrepreneurship, product development, and business strategy within the medical devices industry.

Work Experience 

  • Operational Partner

    2019 - Current

    Thuja Capital manages several venture capital funds aimed at building and scaling companies in the fields of (bio)pharmaceuticals, medtech and digital health. Thuja aims to bring innovations to patients and society by providing capital to daring entrepreneurs with ground-breaking product concepts, addressing unmet medical needs. The investment team of Thuja consists of seasoned investors and entrepreneurs. Consistently performing in the top quartile, the team has backed and helped to build several of today’s unicorns. www.thujacapital.com

  • Chief Executive Officer

    2020

    Hybridize Therapeutics is a biotech spin-off out of the Leiden University Medical Center with a rich history in research & development in RNA-based therapies. Hybridize’s overarching goal is to help patients overcome untreated kidney diseases. We do this by developing RNA-based therapies, i.e. anti-sense oligonucleotides. Currently, we are in the pre-clinical phase for our therapy against BK-virus.

  • Board Member & Treasurer

    2023

    The Netherlands Academy of Engineering, NAE, unites the top experts active in technological sciences and applied research and development. They come from scientific, governmental, and industrial organizations, and share the passion for engineering-based innovation as a means to overcome many of our societal challenges, and to sustain our country’s earning power within the European and international context.

  • Member Of The Supervisory Board

    2019

    LivAssured introduces the NightWatch, a clinically proven wearable detection device that warns parents or caregivers on possible dangerous epileptic seizures at night.

  • Member of The Supervisory Board

    2023

    YES!Delft, one of Europe’s top tech startup incubators since 2005, empowers over 280 innovative startups with unparalleled access to a thriving ecosystem of mentors, investors, and corporate partners, in collaboration with TU Delft and Erasmus University Rotterdam.

  • Investment Committee member Deep Tech Fund

    2022

    The Deep Tech Fund (DTF), a €250mln VC fund by the Dutch Ministry of Economic Affairs and Climate Policy and Invest-NL. DTF invests in knowledge-intensive start-ups and scale-ups in sectors such as photonics, quantum technology, nanotech, medtech, biotech and high tech to strengthen the technological knowledge and international competitive position of the Netherlands.

  • Investment Committee member VGZ Voorop in Zorg Fonds

    2024

    VGZ, a Dutch health insurer, invests 2.5% of its assets (60mln) through a dedicated fund (VGZ Voorop in Zorg fonds) to support companies driving innovation to make healthcare more accessible and affordable.

  • Investment Committee member Pre-Seed Fund

    2022

    Backed by over one hundred successful entrepreneurs including the founders of Picnic and Booking.com, the Graduate Entrepreneur Fund is a €56mln VC fund that envisions to create the cycle ‘from graduate entrepreneurs for graduate entrepreneurs’. As such the fund invests in very early stage technologies including medtech, logistics and AI, preferably coming from the participating universities Delft University of Technology, the Erasmus University Rotterdam and the Erasmus Medical Center.

  • Member

    2023

    The Koninklijke Hollandsche Maatschappij der Wetenschappen (KHMW), the oldest scientific and intellectual society in the Netherlands, has been advancing the connection between science, society, and industry to promote knowledge and innovation since its founding in 1752.

  • Co-Founder & Investor

    2017 - 2021

    The Blue Sparrows MedTech Fund invests money and experience in very early stage medtech companies. The fund is unique in the fact that besides 2 experienced fund managers, a total of 7 young entrepreneurs in medical technology are part of the fund. The aim is to use their recent experience for the purpose of the investments made in the fund. Read more on www.bluesparrows.nl

Articles About Eline

Relevant Websites